Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
Links to CMTA Resources
Learn more CMTA Webinars: www.cmtausa.org/webinars STAR Research: www.cmtausa.org/our-research Dr. Scherer on Pain: www.cmtausa.org/painpdf Ask the Experts: www.cmtausa.org/cmtexperts Neurotoxic Drug List: www.cmtausa.org/medicationlist Connect with us CMTA Facebook Page: www.facebook.com/CMTAssociation…
CMTA Announces Participation in Seed Extension Round for Armatus Bio for Novel CMT1A Gene Therapy
…went on to say that “the venture philanthropy arm will work in tandem with STAR (Strategy to Accelerate Research), the arm of CMTA which is the largest private funder of…
CMTA Awards $225,483 for Study On Using ASOs to Treat CMT2E
…is the largest philanthropic funder of CMT research worldwide. The CMTA’s Strategy to Accelerate Research (STAR) brings the best CMT researchers, clinicians, and experts in therapy development together with patients,…
Medications and Charcot-Marie-Tooth Disease
There currently are no available treatments that act to slow the progression of Charcot-Marie-Tooth disease. There are promising CMT research studies that indicate that this may change in the near…
CMTA Updates List of Neurotoxic Meds Potentially More Hazardous to CMT Patients
…their families. The CMTA has invested $23.5 million in the search for a cure and its Strategy to Accelerate Research (STAR) brings world-renowned CMT researchers together with pharmaceutical and biotechnology…
CMTA Appoints David Apple to Board of Directors
…for a cure and its Strategy to Accelerate Research (STAR) brings world-renowned CMT researchers together with pharmaceutical and biotechnology partners and patients to accelerate scientific breakthroughs. The CMTA also offers…
Sperm Donor with Gene for Charcot-Marie-Tooth Disease Passes It on to Multiple Families
…for patients and their families. The CMTA has invested $23.5 million in the search for a cure and its Strategy to Accelerate Research (STAR) brings world-renowned CMT researchers together with…
Applied Therapeutics Announces Positive Sorbitol Reduction Data From the Ongoing Phase 3 INSPIRE Trial in Sorbitol Dehydrogenase (SORD) Deficiency
NEW YORK, Feb. 16, 2023 (GLOBE NEWSWIRE) — Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications…
Strensall, York CMTA Community Event
07/23/2025 @ 9:00 am – 12:00 pm – You are warmly invited to CMTea! A friendly community get-together hosted by Dr. Katherine Forsey, CMTA’s Chief Research Officer. This community event will be held on Wednesday, 23rd July 2025 from 9am-12pm BST. The event is located at Spearehead Hall Community Cafe, St Mary’s Church Hall, Strensall, York. YO32 5XU. UK. This is an accessible […]
New Mexico CMTA Branch Meeting (Virtual)
02/08/2025 @ 10:00 am – 12:00 pm – Please join us (via Zoom) for the next meeting of the New Mexico CMTA Branch on Saturday, February 8th, at 10 am – Noon Mountain time, when we will gather virtually to watch and discuss the 2024 CMTA Patient and Research Summit. We will be watching the Physical/Occupational Therapy: Help for Today session, followed by […]